Deferasirox 250mg dispersible tablets sugar free
previously Deferasirox 250mg dispersible tablets
- SNOMED code
10841811000001103- Named
- Active compound
- Deferasirox
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Sugar free
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Deferasirox
— 250 mg
based on ingredient substance
- Form & Route
- suspension.oral
Dispersible tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd)
Exjade 250mg dispersible tablets
- SNOMED code
10842011000001101- Supplier
- Novartis Pharmaceuticals UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- Not available
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets10842111000001100 ref. pack |
Discontinued
Legal category: POM | 5010678905243 | No Price Available previously: £235.20 | — |
| — |
Reference packs
Deferasirox 250mg dispersible tablets sugar free 28 tablet
- SNOMED code
10841911000001108- Quantity and unit
- 28 tablet
- Packs